Bullboard - Stock Discussion Forum Biosyent Inc V.RX

Alternate Symbol(s): BIOYF

Healthcare

BioSyent Inc. is a specialty pharmaceutical company. The Company, through its wholly owned subsidiaries, BioSyent Pharma Inc., and BioSyent Pharma International Inc., acquires or licenses and develops pharmaceutical and other healthcare products for sale in Canada and certain international markets. Hedley Technologies Ltd., a wholly owned subsidiary operates the Company’s business marketing... see more

Add To Watchlist

TSXV:RX - Post Discussion

Biosyent Inc > Earnings Release Scheduled

View:

Post by overnout on Mar 11, 2021 8:50am

Earnings Release Scheduled

MISSISSAUGA, Ontario, March 11, 2021 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) will be reporting its financial results for the three months and full year ended December 31, 2020 on Wednesday, March 17, 2021. A presentation on the Company’s fourth quarter and full year 2020 results by Ren Goehrum, BioSyent President and CEO, will also be available on the Company’s website on the date of release.

140

Comment

Comment by theinvestor22 on Mar 11, 2021 9:08am

It won't be the Q4 earnings that will be of primary importance to me, although there might be some Tibella revenue plus a small amount of revenue from initial filling up of the supply chain from Combogesic. The important thing for me will be the CEO's commentary on the potential take-up of Combogesic. Of course, launching new products during a pandemic can't be easy, but ...more

169

Comment

Biosyent Inc